Welcome to our dedicated page for Acme United SEC filings (Ticker: ACU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Acme United Corporation filings document the formal disclosures of an operating company that supplies first aid and medical products, safety solutions and cutting technology. Its 8-K reports include operating and financial results, material-event disclosures, acquisition-related reporting, credit-facility matters and other corporate updates affecting the company's capital and operating structure.
ACU proxy and annual-meeting filings cover board elections, executive compensation votes, equity incentive plan amendments and auditor ratification. The company's regulatory record also includes material agreement disclosures, including amendments to its secured revolving credit facility, along with governance matters and shareholder voting results.
ACME UNITED CORP director and CEO Walter C. Johnsen reported a bona fide gift of 5,834 shares of Common Stock on May 27, 2026. The shares were transferred at a reference price of $42.23 per share. After the gift, he directly holds 314,999 Common Stock shares.
ACME UNITED CORP director and President/COO Brian S. OlschAN reported an open-market sale of company stock. On May 28, 2026, he sold 4,833 shares of ACME UNITED CORP common stock at a price of $42.00 per share.
Following this transaction, he directly holds 41,172 shares of common stock. The filing reports no associated derivative security exercises, conversions, or tax-withholding transactions.
ACME United Corp. reported an insider sale notice: 15,000 shares were listed for sale by Brian Olschan. The filing shows $688,200.00 tied to the reported transaction date 02/27/2026. The notice also lists stock awards dated 06/17/2025 (37 shares) and 05/22/2026 (4,796 shares).
ACME United Corp President and COO Brian Olschan exercised employee stock options for 20,000 shares of Common Stock at $24.92 per share. To cover tax obligations, 15,204 shares were disposed of at $43.21 per share through share withholding, not an open-market sale. After these transactions, he directly holds 61,209 Common shares and 241,700 employee stock options.
ACME UNITED CORP director and CEO Walter C. Johnsen exercised stock options and had shares withheld for taxes. He exercised 30,000 Employee Stock Options at $23.99 per share, converting them into Common Stock in a routine compensation-related move.
To cover tax obligations, 24,166 Common Stock shares were disposed of at $40.53 per share through a tax-withholding transaction, not an open-market sale. After these transactions, Johnsen directly owns 320,833 Common Stock shares.
Acme United’s first quarter 2026 showed higher sales but lower profit. Net sales rose to $52.3 million, up 14% from a year earlier, helped by stronger first aid and medical demand and the January acquisition of My Medic. Excluding My Medic, comparable sales grew 6%.
Net income fell to $1.0 million from $1.7 million as higher tariffs, quality investments and personnel costs pushed selling and administrative expenses up to $19.0 million. Diluted EPS declined to $0.24 from $0.41. Operating cash flow was a use of $2.2 million, mainly from higher receivables and inventory.
The company bought My Medic for $18.6 million (including contingent and holdback amounts); the business added $3.4 million in revenue. To fund the deal and working capital, borrowings under the revolving credit facility increased to $33.0 million, raising the long‑term debt to equity ratio to 36.3%. Management says it remains in covenant compliance and views existing cash and credit capacity as sufficient for the next twelve months.
ACME United Corporation reported the results of its 2026 Annual Meeting of Shareholders held on April 27, 2026. Shareholders elected all seven director nominees, each receiving over 2.82 million votes for, with relatively few votes withheld.
Investors approved an amendment to the 2022 Employee Stock Option Plan with 1,951,474 votes for and 925,794 against, and supported a non-binding advisory resolution on named executive officer compensation with 2,775,611 votes for and 102,051 against. Shareholders also ratified the appointment of CBIZ CPA's, P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 3,413,803 votes in favor.
Acme United Corporation reported higher sales but lower profits for the quarter ended March 31, 2026. Net sales rose to $52.3 million from $46.0 million a year earlier, a 14% increase, or 6% growth excluding the My Medic acquisition.
Net income declined to $1.0 million, or $0.24 per diluted share, from $1.7 million, or $0.41 per diluted share, as higher cost of sales and operating expenses offset revenue gains. The company cited tariff-related costs, enhanced quality assurance spending at the Med-Nap facility, and rising employee healthcare costs as key drivers.
Acme highlighted contributions from the recently acquired My Medic business, which has annual sales of $19 million but minimal first-quarter profit due to seasonality. U.S., European, and Canadian segments all posted double-digit sales growth in U.S. dollars. Bank debt less cash increased to $38.6 million, reflecting the My Medic acquisition, a German product line purchase, dividends, a new Tennessee facility, and inventory builds to mitigate supply risks from the conflict in Iran.
Acme United Corporation had a Schedule 13G/A amendment reporting that The Capital Management Corporation beneficially owned 500,967.30 shares of Common stock, representing 13.2% of the class as of 03/31/2026. The filing states sole voting power of 496,192.30 shares and sole dispositive power of 500,967.30 shares. The filing was signed by Pamela Simms as Compliance Officer on 04/02/2026.